Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis

The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice

(2010) R. P. Hebbel et al.   BLOOD

SIRT1 Promotes Proliferation and Prevents Senescence Through Targeting LKB1 in Primary Porcine Aortic Endothelial Cells

(2010) Yi Zu et al.   CIRCULATION RESEARCH

Histone Deacetylase 7 Controls Endothelial Cell Growth Through Modulation of β-Catenin

(2010) Andriana Margariti et al.   CIRCULATION RESEARCH

Inhibitors of HDACs - Effective Drugs Against Cancer?

(2010) S. Muller et al.   CURRENT CANCER DRUG TARGETS

Early Apoptotic Vascular Signaling is Determined by Sirt1 Through Nuclear Shuttling, Forkhead Trafficking, Bad, and Mitochondrial Caspase Activation

(2010) Jinling Hou et al.   CURRENT NEUROVASCULAR RESEARCH

Induction of E-Cadherin in Lung Cancer and Interaction with Growth Suppression by Histone Deacetylase Inhibition

(2010) Masatoshi Kakihana et al.   Journal of Thoracic Oncology

Epigenetics and cardiovascular disease

(2010) José M. Ordovás et al.   Nature Reviews Cardiology

Molecular Signals of Epigenetic States

(2010) Roberto Bonasio et al.   SCIENCE

HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells

(2009) C. Urbich et al.   BLOOD

Trichostatin A enhances proliferation and migration of vascular smooth muscle cells by downregulating thioredoxin 1

(2009) Seungjeong Song et al.   CARDIOVASCULAR RESEARCH

Histone Deacetylase 3 Is Critical in Endothelial Survival and Atherosclerosis Development in Response to Disturbed Flow

(2009) Anna Zampetaki et al.   CIRCULATION

NAD+, Sirtuins, and Cardiovascular Disease

(2009) Nica Borradaile et al.   CURRENT PHARMACEUTICAL DESIGN

Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease

(2009) D. Pons et al.   EUROPEAN HEART JOURNAL

Histone deacetylases modulate vascular smooth muscle cell migration induced by cyclic mechanical strain

(2009) Zhi-Qiang Yan et al.   JOURNAL OF BIOMECHANICS

Splicing of HDAC7 modulates the SRF-myocardin complex during stem-cell differentiation towards smooth muscle cells

(2009) A. Margariti et al.   JOURNAL OF CELL SCIENCE

Histone deacetylase inhibitors: Potential in cancer therapy

(2009) P.A. Marks et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

VEGF Stimulates HDAC7 Phosphorylation and Cytoplasmic Accumulation Modulating Matrix Metalloproteinase Expression and Angiogenesis

(2008) Chang Hoon Ha et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

HDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2

(2008) Annamaria Scognamiglio et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Stem Cells and Transplant Arteriosclerosis

(2008) Qingbo Xu   CIRCULATION RESEARCH

Isoform-Selective Histone Deacetylase Inhibitors

(2008) Takayoshi Suzuki et al.   CURRENT PHARMACEUTICAL DESIGN

The many roles of histone deacetylases in development and physiology: implications for disease and therapy

(2008) Michael Haberland et al.   NATURE REVIEWS GENETICS